Serum insulin-like growth factor is not a useful marker of prostate cancer

被引：0
|
作者：
Serel, TA [1 ]
Kecelioglu, M [1 ]
机构：
[1] Suleyman Demirel Univ, Isparta, Turkey
来源：
BJU INTERNATIONAL | 2000年 / 85卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [1] Serum insulin-like growth factor-1 is not a useful masker of prostate cancer
    Cutting, CWM
    Hunt, C
    Nisbet, JA
    Bland, JM
    Dalgleish, AG
    Kirby, RS
    BJU INTERNATIONAL, 1999, 83 (09) : 996 - 999
  • [2] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer
    Zancan, M.
    Dittadi, R.
    Scattoni, V.
    Fandella, A.
    Del Bianco, P.
    Gion, M.
    EJC SUPPLEMENTS, 2007, 5 (08): : 36 - 36
  • [3] Correlation of Serum Insulin-like Growth Factor 1 with Prostate Cancer
    Ayati, Mohsen
    Zeighami, Shahryar
    Safavi, Majeed
    Nowroozi, Mohammad Reza
    Jamshidian, Hasan
    Meysamie, Alipasha
    MIDDLE EAST JOURNAL OF CANCER, 2012, 3 (04) : 95 - 99
  • [4] Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
    Finne, P
    Auvinen, A
    Koistinen, H
    Zhang, WM
    Määttänen, L
    Rannikko, S
    Tammela, T
    Seppälä, M
    Hakama, M
    Stenman, UH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08): : 2744 - 2747
  • [5] Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis
    Rainato, Giulia
    Fabricio, Aline S. C.
    Zancan, Matelda
    Peloso, Lucia
    Dittadi, Ruggero
    Barichello, Mario
    Fandella, Andrea
    Scattoni, Vincenzo
    Gion, Massimo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2016, 31 (03): : E317 - E323
  • [6] Insulin-like growth factor I and prostate cancer
    O'Brien, MF
    Watson, RWG
    Fitzpatrick, JM
    UROLOGY, 2001, 58 (01) : 1 - 7
  • [7] Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer
    Miyata, Y
    Sakai, H
    Hayashi, T
    PROSTATE, 2003, 54 (02): : 125 - 132
  • [8] Serum insulin-like growth factor 1: Tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men
    Woodson, K
    Tangrea, JA
    Pollak, M
    Copeland, TD
    Taylor, PR
    Virtamo, J
    Albanes, D
    CANCER RESEARCH, 2003, 63 (14) : 3991 - 3994
  • [9] Insulin-like growth factor (IGF) family and prostate cancer
    Gennigens, C.
    Menetrier-Caux, C.
    Droz, J. P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (02) : 124 - 145
  • [10] Changes in the insulin-like growth factor system in prostate cancer
    Tennant, MK
    Thrasher, JB
    Maddison, L
    Plymate, SR
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A154 - A154
12345